Author: Duc Duy Nguyen; Kaifu Gao; Jiahui Chen; Rui Wang; Guo-Wei Wei
Title: Potentially highly potent drugs for 2019-nCoV Document date: 2020_2_13
ID: g5wpa2ee_4
Snippet: Recently, we have developed low-dimensional mathematical representations [9, 10] to reduce the structural complexity of macromolecules based on abstract mathematics, such as algebraic topology [17] [18] [19] [20] , differential geometry, and spectral graph theory [10, 21] . We exploit these representations to extract critical chemical and biological information for protein-ligand pose selection, binding affinity ranking, prediction, ranking, scor.....
Document: Recently, we have developed low-dimensional mathematical representations [9, 10] to reduce the structural complexity of macromolecules based on abstract mathematics, such as algebraic topology [17] [18] [19] [20] , differential geometry, and spectral graph theory [10, 21] . We exploit these representations to extract critical chemical and biological information for protein-ligand pose selection, binding affinity ranking, prediction, ranking, scoring, and screening [9, 10] . Paired with various machine learning, including deep algorithms, these approaches are the top competitor for D3R Grand Challenges, a worldwide competition series in computer-aided drug design in the past few years [22, 23] .
Search related documents:
Co phrase search for related documents- critical chemical and machine learning: 1, 2, 3, 4
- critical chemical and protein ligand: 1
- deep algorithm and drug design: 1
- deep algorithm and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- deep algorithm and protein ligand: 1, 2
- deep algorithm and structural complexity: 1
- differential geometry and drug design: 1, 2
- differential geometry and mathematical representation: 1
- differential geometry and protein ligand: 1
- drug design and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- drug design and mathematical representation: 1
- drug design and protein ligand: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- drug design and structural complexity: 1
- machine learning and mathematical representation: 1, 2
- machine learning and past year: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- machine learning and protein ligand: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- machine learning and structural complexity: 1
- past year and protein ligand: 1
Co phrase search for related documents, hyperlinks ordered by date